Robert Grissom
Urology · Baton Rouge, LANPI 1457388639
Payments from drug & device makers
Across 168 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$579
- Sumitomo Pharma America, Inc.$407
- Johnson & Johnson$249
- Dendreon Pharmaceuticals LLC$233
- AbbVie$165
- Bayer$107
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,934100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 43 | $579 |
| Sumitomo Pharma America, Inc. | 21 | $407 |
| Johnson & Johnson(2 entities) | 18 | $249 |
| Dendreon Pharmaceuticals LLC | 10 | $233 |
| AbbVie(2 entities) | 11 | $165 |
| Bayer | 7 | $107 |
| Blue Earth Diagnostics | 5 | $104 |
| Antares Pharma, Inc. | 6 | $94 |
| 180 Medical, Inc. | 4 | $92 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $84 |
| Procept Biorobotics Corporation | 2 | $84 |
| Endo Pharmaceuticals Inc. | 5 | $83 |
| Progenics Pharmaceuticals, Inc. | 2 | $70 |
| Hollister Incorporated | 3 | $64 |
| Urovant Sciences Inc | 2 | $52 |
| Accord Healthcare, Inc. | 3 | $51 |
| Teleflex LLC | 1 | $50 |
| Myriad Genetic Laboratories, Inc. | 2 | $45 |
| Tolmar Pharmaceuticals, Inc. | 2 | $40 |
| Rochester Medical Corporation | 3 | $38 |
| Neotract Inc. | 1 | $27 |
| Pfizer | 2 | $26 |
| Acerus Pharmaceuticals Corporation | 2 | $25 |
| Clarus Therapeutics Inc. | 2 | $25 |
| Merck | 1 | $21 |
| Agiliti Surgical, Inc. | 1 | $20 |
| Ambu Inc. | 1 | $19 |
| Tolmar, Inc. | 1 | $18 |
| Dornier Medtech America, Inc | 1 | $18 |
| Axonics, Inc. | 1 | $16 |
| Myovant Sciences Inc. | 1 | $15 |
| Urogen Pharma, Inc. | 1 | $14 |
How this compares
$2,934 in reported general payments places this provider in the 50th percentile of 199 urology providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 44 | $25,431 |
| GemtesaVibegron | 16 | $14,195 |
| Tamsulosin Hcl | 241 | $2,279 |
| Silodosin | 12 | $1,862 |
| Finasteride | 110 | $1,155 |
| NitrofurantoinNitrofurantoin Macrocrystal | 26 | $602 |
| Ciprofloxacin Hcl | 39 | $517 |
| Desmopressin Acetate | 12 | $415 |
| Oxybutynin Chloride ErOxybutynin Chloride | 30 | $325 |
| Doxycycline Monohydrate | 12 | $281 |
| Fluconazole | 16 | $106 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $67 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $579 | $25,43144 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $407 | $14,19516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 199 urology providers in Louisiana.
Other urology in Baton Rouge
- Jason BridgesBaton Rouge$15K
- James MorrisBaton Rouge$8K
- Stephen VickBaton Rouge$7K
- Ralph HendersonShreveport$4M
- Kevin ClineShreveport$1.3M
- Nathan FischmanNew Orleans$1.3M
- Ashley BakerShreveport$705K
- Colin GoudelockeNew Orleans$615K
- Stephen BardotNew Orleans$572K
- Gerard HenryBossier City$489K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.